Halozyme Therapeutics, Inc. (HALO)

62.17 +0.30 (+0.48%) USD  |  NASDAQ  |  Dec 10, 11:51
More

Halozyme Therapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Twist Bioscience Corp. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
Revenue (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Gross Profit Margin (Quarterly) Upgrade
Profit Margin (Quarterly) Upgrade
Earnings Yield Upgrade
Operating Earnings Yield Upgrade
Normalized Earnings Yield Upgrade